ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Alpha Cognition Inc

Alpha Cognition Inc (ACOG)

0.24
0.00
(0.00%)
Cerrado 12 Agosto 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.24
Postura de Compra
0.23
Postura de Venta
0.30
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.24
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
118,208,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.86
Beneficio por acción (BPA)
-0.12
turnover
-
Beneficio neto
-13.77M

Acerca de Alpha Cognition Inc

Sector
Pharmaceutical Preparations
Industria
Finance Services
Sede
Vancouver, British Columbia, Can
Fundado
2021
Alpha Cognition Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker ACOG. The last closing price for Alpha Cognition was $0.24. Over the last year, Alpha Cognition shares have traded in a share price range of $ 0.00 to $ 0.00.

Alpha Cognition currently has 118,208,000 shares in issue. The market capitalisation of Alpha Cognition is $28.37 million. Alpha Cognition has a price to earnings ratio (PE ratio) of -0.86.

ACOG Últimas noticias

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

Alpha Cognition Inc. (OTCQB: ACOG) (CSE: ACOG) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today...

Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Provides Private Placement Update

Not for distribution in the United States or to U.S. newswire services Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company...

Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Withdrawal of Marketed Public Offering

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Marketed Offering

NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23rd Life...

Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
156-0.69-74.19354838710.932.490.21243150.92810967CS
260-1.13-82.48175182481.372.490.21221730.93850865CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EKGCardioComm Solutions Inc
$ 0.015
(200.00%)
39.08k
TAB.HTablas Ventures Corp
$ 0.135
(170.00%)
57.06k
MKTDeepMarkit Corp
$ 0.19
(153.33%)
59k
RRM.HRoss River Minerals Inc
$ 0.055
(120.00%)
15k
GPMGPM Metals Inc
$ 0.095
(90.00%)
237.1k
RAKRackla Metals Inc
$ 0.05
(-58.33%)
1.24M
KWEKwesst Micro Systems Inc
$ 0.19
(-44.12%)
295.53k
RCTRochester Resources Ltd
$ 0.02
(-42.86%)
2.86k
CLMConsolidated Lithium Metals Inc
$ 0.01
(-33.33%)
35k
RSC.PRockmount Capital Corporation
$ 0.10
(-33.33%)
15k
EACEarth Alive Clean Technologies Inc
$ 0.005
(0.00%)
4.5M
THRMTherma Bright Inc
$ 0.065
(18.18%)
4.33M
RHCRoyal Helium Ltd
$ 0.07
(40.00%)
2.15M
PPXPPX Mining Corp
$ 0.04
(-11.11%)
1.63M
BTRBonTerra Resources Inc
$ 0.305
(45.24%)
1.46M
iwfal iwfal 2 minutos hace
I'm wondering if management comes out of this with shares in the new enterprise in some kind of backdoor deal. That's the only way this would make sense to me.

That seems virtually certain since the one thing he's good at is greasing his own palms - the compensation he was getting was
Schrodingers Cat Schrodingers Cat 2 minutos hace
Aug 12 short volumes: CODX 9%, FLGT 48%, QDEL 70%, VERU 81%.
CODX VERU
1vman 1vman 2 minutos hace
***** 🅰️🅰️🅰️The outcome of current lawsuit will turn out very bad for NRDE ( Pu ride ) -- stock is toast

ENOUGH SAID
NRDE
bobbleheadtwin bobbleheadtwin 2 minutos hace
Good laugh
https://www.lse.co.uk/ShareChat.html?ShareTicker=AYM&share=Anglesey-Mining
LBRMF
Huggy Bear Huggy Bear 2 minutos hace
You wouldn't know the truth unless a brick hit you upside the head.
KEGS
flipper44 flipper44 4 minutos hace
SMH.
SMH
fuagf fuagf 4 minutos hace
Like i've said before do appreciate most of your posts, just the gratuitous bitches at the
board are unwarranted. Our two habitual whiners are two more than enough of that.

LOL i see one has attached to you yet again. You are welcome to him.
louieforpar louieforpar 4 minutos hace
https://t.co/iSpF81rnNR
wildwertski wildwertski 4 minutos hace
Well Mighty, we are now at 365 + days, well past the original 120 day time frame ST3 gave for his uplist, (08-10-2023 interview) and share price is in no position for uplist. It’s still in trips, and the stock has dropped to the expert market numerous times. Plus, lots of dilution, IST gone, no Tusk
TPTW
Chartmaster Chartmaster 5 minutos hace
It's falling on the Breakout Board, that's never a good sign
ASII
bunda bunda 5 minutos hace
Waiting for 2.50
NIO
Doc328 Doc328 5 minutos hace
You are conveniently ignoring the huge number of patients who dropped out during the up-titration. The FDA and EMA won't.

The safety population (all patients receiving one or more dose) was n=167, 168 and 168 for 30 mg. 50 mg and placebo.
After up-titration n was 154, 144 a
AVXL
alertmeipp alertmeipp 5 minutos hace
that sucks.....but at least you have tried. Best wishes for your next longs.
RVNC
ilovetech ilovetech 5 minutos hace
Worth repeating IMHO. Virtu's plea for dismissing the SEC lawsuit against it was authoritatively denied. Judge said "it made no sense..." That's the first wrinkle in the veneer of invulnerability for Virtu. The defense attorney asked for a partial discovery 😭🤡 If that doesn't scream
NWBO
al44 al44 5 minutos hace
Would love to see this-

https://media.gettr.com/group6/getter/2024/08/11/15/b690e156-7187-707a-c5ee-b774ea41b753/aa869688a686e1b1c1f8d18b3328722c_768x0.jpg
jay_tee jay_tee 5 minutos hace
Oh lawd from one extreme to the other!!! lol MLK to Stormy!! Lol
FOXO
joemax444 joemax444 6 minutos hace
I like the stock!! Let's go!
KRKNF
Grasshopper Grasshopper 6 minutos hace
Very diplomatic! Good work!
HIRU
Chartmaster Chartmaster 6 minutos hace
#6 Breakout Board! Chart's an easy read!
https://investorshub.advfn.com/uimage/uploads/2024/8/12/ukbpdEMED_8-12-24.PNG
EMED
mc73 mc73 6 minutos hace
I emailed once over a year ago, can't remember what I said but I know I didn't get a response.

I am willing to wait another week or two to hear something as I am guessing getting the FDA to meet up takes some time.
RDGL
nelson1234 nelson1234 8 minutos hace
AP ok, I agree that it sounds like things won't be getting better. I just didn't see something which said definitively things are getting worse.
TooFrank TooFrank 8 minutos hace
Creamy Soft Leggings Walmart search

https://www.google.com/search?q=creamy+soft+leggings+walmart&ie=UTF-8&oe=UTF-8&hl=en-us&client=safari
BRAV
Eli's Gone Eli's Gone 8 minutos hace
He's had a good summer---can afford a bunch of fish and chips
skitahoe skitahoe 8 minutos hace
I believe that GBM can be earning NWBO several billion dollars a year by later this decade. With rapid earnings growth, NWBO should justify a P-E of 30. Market cap should be XX billion times 30. Even if XX is only two, we're looking at over $50 billion.

Gary
NWBO

Su Consulta Reciente

Delayed Upgrade Clock